Dolores Schendel
Company: Medigene
Job title: Chief Scientific Officer
Seminars:
Incorporating Modular Control into Cell Therapies through Receptors to Enhance Therapy Persistence & Safety 1:00 pm
Attend this workshop to: Assess options to achieve modular control such as logic gating and switch receptors to boost specific efficacy at tumour site Implement a switch receptor to allow precise control of cells to minimise toxicity Educate clinicians on when and how to use switch receptors to modulate or terminate expression levels in patientsRead more
day: Workshop D - Mid
Developing Effective Methods to Monitor, Track & Assess T-Cell Efficacy In Vivo & In Vitro 5:30 pm
Engineering a tag into T-cells to assess and track function in patients Monitoring T-cell activity in vivo to uncover mechanism of action Harnessing engineered tags to detect surrogate biomarkers to imply clinical efficacyRead more
day: Day 1 - Track B - PM